The medical management of glaucoma

South African Family Practice

 
 
Field Value
 
Title The medical management of glaucoma
 
Creator Marais, André Osuch, Elzbieta
 
Subject — Glaucoma; prostaglandin analogs; carbonic anhydrase inhibitors; beta antagonists, alpha 2 adrenergic agonists; cholinergic agonists
Description Glaucoma is one of the leading causes of blindness worldwide. The main characteristic features include optic disc cupping, visual field loss, and in most instances a raised intraocular pressure. Primary open angle glaucoma accounts for nearly two thirds of all cases, while angle closure glaucoma contributes the majority of the remainder. Screening for glaucoma is not cost-effective, and diagnosis of the primary open angle type is usually an incidental finding during ophthalmological examination. Various treatment options, including medical and surgical interventions are accessible in the management of glaucoma. This article contains a brief description on the pathophysiology and focuses on the pharmacological options available in the treatment of glaucoma.
 
Publisher AOSIS
 
Contributor
Date 2017-05-11
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article —
Format application/pdf
Identifier 10.4102/safp.v59i2.4669
 
Source South African Family Practice; Vol 59, No 2 (2017): March/April; 6-13 2078-6204 2078-6190
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://safpj.co.za/index.php/safpj/article/view/4669/5540 https://safpj.co.za/index.php/safpj/article/downloadSuppFile/4669/1583
 
Coverage — — —
ADVERTISEMENT